WuXi Biologics Achieves Prestigious Platinum Medal for Sustainability for the Second Year in a Row
WuXi Biologics Recognized for Sustainability Excellence
In a significant achievement, WuXi Biologics, a prominent player in the global Contract Research, Development, and Manufacturing Organization (CRDMO) sector, has once again been awarded the prestigious Platinum Medal by EcoVadis. This recognition not only highlights the company's commitment toward sustainability but also marks the second consecutive year it has attained this accolade, positioning WuXi Biologics among the elite 1% of more than 150,000 evaluated companies across 185 countries.
The EcoVadis Sustainability Rating is pivotal in assessing corporate sustainability efforts through a structured lens that encompasses crucial management indicators. These indicators reflect performance across four main themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. The comprehensive assessment takes into account various elements, including a company's governance, policies, and operational outcomes, ultimately providing insights into their sustainability practices as viewed by external stakeholders.
Dr. Chris Chen, CEO of WuXi Biologics and Chairman of its ESG Committee, articulated the significance of this recognition: "We are very pleased to be once again recognized by EcoVadis with the Platinum Medal, which reflects our success in enhancing our sustainability capabilities. As a global leader in Green CRDMO, we are committed to continuously delivering ESG excellence, enabling partners worldwide to fulfill ESG goals, and jointly working with all stakeholders to promote responsible practices throughout the entire value chain."
WuXi Biologics' proactive commitment to sustainability aligns with global initiatives like the United Nations Global Compact (UNGC) and the Pharmaceutical Supply Chain Initiative (PSCI). The company has consistently earned accolades for its efforts in advocating sustainability in the pharmaceutical landscape. Noteworthy achievements include being featured in the UNGC's 20 Case Examples of Sustainable Development for a 20-year collection and securing an MSCI AAA Rating, reinforcing its status as a leader in sustainable practices.
Furthermore, WuXi Biologics has made its mark on prestigious sustainability indices, being listed in the Dow Jones Sustainability Indices for two consecutive years. It has also established itself as a top-rated entity by Sustainalytics for five years running, positioning itself as a preferred partner in the industry.
The company's dedication to environmental sustainability extends to tangible results; WuXi Biologics has been recognized in the CDP Water Security